Difference between revisions of "Danazol (Danocrine)"
Jump to navigation
Jump to search
m |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Immune thrombocytopenia (ITP)]] | *[[Immune thrombocytopenia (ITP)]] | ||
| + | *[[Myelofibrosis]] | ||
| + | |||
| + | ==Diseases for which it was used== | ||
| + | *[[Breast cancer - historical|Breast cancer]] | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * | + | *1976-06-21: Initial FDA approval |
==Also known as== | ==Also known as== | ||
| Line 16: | Line 20: | ||
[[Category:Immune thrombocytopenia medications]] | [[Category:Immune thrombocytopenia medications]] | ||
| + | [[Category:Myelofibrosis medications]] | ||
| + | |||
| + | [[Category:Breast cancer medications (historic)]] | ||
| − | [[Category:FDA approved in | + | [[Category:FDA approved in 1976]] |
| − | |||
Latest revision as of 00:18, 7 May 2023
Mechanism of action
Synthetic steroid with multiple mechanisms of action.
Diseases for which it is used
Diseases for which it was used
History of changes in FDA indication
- 1976-06-21: Initial FDA approval
Also known as
- Brand names: Danatrol, Danocrine, Danodiol, Danogen, Drane, Ladogal, Novaprin